HEALTH: First Ever HIV Prevention Pill 'Truvada' Gets FDA Approval

Remember the name Truvada. You may be needing it later (although I pray that never comes true).

Earlier this week the Food & Drug Administration approved Truvada by Gilead Sciences, Inc. as pre-exposure prophylaxis -referred to as PrEP in the industry. This is the first pill in U.S. history to accomplish the feat.

How does it work?
Truvada combines two medicines: Emtricitabine and tenofovir disoproxil fumarate. Together, Truvada blocks an enzyme in your body HIV virus uses to recreate positive cells.

How effective is it?
Depending on where you look and which study you refer to. Truvada has proven to reduce the risk of spreading HIV approximately 45% among same-sex couples where one partner has the virus. Heterosexuals couples see a better benefit, reducing the risk 70%-75% of the time.

How much does it cost?
I think you’d be better off wearing a condom, unless you have $14,000 a year laying around. Doctors also recommend getting tested every few months while on the drug EVEN THOUGH you should already be doing that anyway.

Are there side effects?
An article by The New York Times says Truvada can cause upset stomach the first few weeks you take the drug, in addition to kidney problems and bone thinning.

Experts who rallied against the approval of this new once-a-day pill said people struggle to keep hold of taking pills everyday. If you miss a dose of Truvada and acquire HIV, your body will become immune to the pill. Researchers also admit while testing Truvada during one of their studies only 10% of participants actually took the pill everyday as required.

In closing, Truvada’s approval is a major step in the fight to reduce HIV/AIDS infections in America. That alone deserves a round of applause! Clap dammit!

For more info on Truvada visit their official website.


Leave a comment

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Your email is never shared. Required fields are marked *